Digimarc CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Digimarc CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $4.86M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $8.68M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $5.59M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $6.09M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $5.18M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $5.58M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $5.46M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $5.58M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $5.02M | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $5.39M | Feb 23, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.91M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $38.42M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $34.85M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $30.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $26.52M | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | $5.55M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $5.75M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $6.50M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $6.19M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $5.32M | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.90M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $24.24M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $20.17M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $15.32M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $17.74M | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | $3.86M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $3.82M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $4.38M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $3.99M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $3.52M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($32.31M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($39.01M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($45.96M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($59.80M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($34.76M) | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | ($7.82M) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | ($8.35M) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | ($7.46M) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | ($8.91M) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | ($8.68M) | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($33.16M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($41.31M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($48.21M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($61.81M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($39.87M) | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | ($7.83M) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | ($8.39M) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | ($7.54M) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | ($9.06M) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | ($8.88M) | Feb 26, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.48M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $26.21M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $26.58M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $26.49M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $17.54M | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | $4.01M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $4.66M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $4.21M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $4.43M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $4.34M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.78M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($26.57M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($22.00M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($44.41M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($26.12M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($19.94M) | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | ($21.70M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($21.21M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($17.61M) | Feb 22, 2019 |
| FY2013 | Dec 31, 2013 | $3.47M | Feb 21, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $570.0K | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $212.0K | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $314.0K | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $934.0K | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $966.0K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $1.02M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $1.06M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.29M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.19M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.84M | Feb 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.96M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $75.77M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $80.55M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $113.78M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $64.88M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $97.03M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $57.39M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $61.79M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $88.37M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $78.74M | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.73M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $14.41M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $18.63M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $16.19M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $9.50M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $13.19M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $7.94M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $5.17M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $6.02M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $5.40M | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.23M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $61.36M | Mar 11, 2026 |
| FY2025 | Dec 31, 2023 | $61.93M | Mar 11, 2026 |
| FY2024 | Dec 31, 2022 | $97.59M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $55.38M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $83.84M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $49.45M | Mar 7, 2022 |
| FY2020 | Dec 31, 2018 | $56.62M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $82.35M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $73.33M | Feb 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.06M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.53M | Mar 11, 2026 |
| FY2025 | Dec 31, 2023 | $8.64M | Mar 11, 2026 |
| FY2024 | Dec 31, 2022 | $8.23M | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $1.11M | Mar 2, 2023 |
| FY2023 | Dec 30, 2021 | $1.11M | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $1.11M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $1.11M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.11M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.11M | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($383.09M) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | ($350.78M) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | ($311.77M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($265.81M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($206.01M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($171.25M) | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | ($138.72M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($105.88M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($73.51M) | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | ($47.71M) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.82M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $12.37M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $21.46M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $33.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $13.79M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $19.70M | Mar 7, 2022 |
| FY2021 | Dec 31, 2019 | $11.21M | Mar 7, 2022 |
| FY2020 | Dec 31, 2018 | $27.28M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $40.82M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $11.64M | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $5.03M | Feb 26, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | (1) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 2, 2023 |
| FY2020 | Dec 31, 2020 | (1) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.90M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 21.50M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 20.38M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 20.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 16.94M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 16.74M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | 12.45M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 11.89M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 11.65M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 10.52M | Feb 22, 2018 |